Social networks
2,916Entity types
Location
11 Rue de l'Académie, 67000 Strasbourg, France
Strasbourg
France
Employees
Scale: 2-10
Estimated: 8
Engaged corporates
43Added in Motherbase
1 year, 3 months ago[Automatic translation follows] Healthcare accelerator in the heart of Europe.
For biotech, medtech and digital health startups.
Quest for health is the Grand Est incubator dedicated to healthcare start-ups at the European level. Born from the initiative of the Quest for change incubator network (located in Reims, Strasbourg, Metz, Charleville-Mézières, Epinal and Mulhouse), the incubator supports more than sixty biotech, medtech and e-health start-ups. Quest for health is positioned as the leading national player in this field.
Among the supported start-ups, 21 are winners of the national i-Lab competition (including four grand prizes), five of the i-Nov competition and two of the EIC Accelerator. In 2021, they raised a total of €55 million in funds on contracted valuations of €190 million.
Quest for health aims to develop health innovation in the Grand Est region but also internationally. With the support of its German and Swiss partners, the incubator brings entrepreneurs as quickly as possible to the important milestones of their project development via pragmatic, caring and impartial support, supervised by a team of experts, mainly composed of entrepreneurs.
Launched in December 2022, the incubator is located within Nextmed, a medical technology campus in Strasbourg.
Healthcare accelerator in the heart of Europe.
For biotech, medtech and digital health startups.
Quest for health est l’incubateur du Grand Est dédié aux start-up santé au niveau européen. Né à l’initiative du réseau d’incubateurs Quest for change (implanté à Reims, Strasbourg, Metz, Charleville-Mézières, Epinal et Mulhouse), l’incubateur accompagne plus de soixante start-up biotech, medtech et e-santé. Quest for health se positionne comme le premier acteur au niveau national dans ce domaine.
Parmi les start-up accompagnées, 21 sont lauréates du concours national i-Lab (dont quatre grands prix), cinq du concours i-Nov et deux de l’EIC Accelerator. En 2021, elles ont levé un total de 55M€ de fonds sur des valorisations contractualisées de 190M€.
Quest for health souhaite développer l’innovation santé dans le Grand Est mais également à l’international. Avec l’appui de ses partenaires allemands et suisses, l’incubateur amène les entrepreneurs le plus rapidement possible vers les jalons importants du développement de leur projet via un accompagnement pragmatique, bienveillant et impartial, encadré par une équipe d’experts, composée essentiellement d’entrepreneurs.
Lancé en décembre 2022, l’incubateur est installé au sein de Nextmed, campus des technologies médicales à Strasbourg.
Quest for health est une opportunité unique pour les start-up santé d’accélérer leur développement au cœur de l’Europe.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Retis Government Administration | Retis Government Administration | Other 24 Sep 2024 | | |
Finovam Gestion Venture Capital and Private Equity Principals | Finovam Gestion Venture Capital and Private Equity Principals | Other 30 Sep 2024 | | |
Elaia Startup accelerator & VC, Venture Capital and Private Equity Principals | Elaia Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 27 Apr 2024 | | |
Eurazeo Finance, Financial Services | Eurazeo Finance, Financial Services | Other 1 Apr 2024 | | |
50 Partners Startup accelerator & VC, Venture Capital & Private Equity | 50 Partners Startup accelerator & VC, Venture Capital & Private Equity | Other 27 Apr 2024 | | |
SATT Nord | Other 29 Feb 2024 | | ||
Gouvernement | Other 30 Apr 2024 | | ||
Sofinnova Partners Financial Services | Sofinnova Partners Financial Services | Other 22 Feb 2024 | | |
Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Other 7 Mar 2024 | | |
Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Other 1 Apr 2024 | |